FDA Revives Wellcovorin Tablets for Patient Use
Published Date: 9/24/2025
Notice
Summary
The FDA just gave the green light again to Wellcovorin tablets, a medicine that helps patients during certain cancer treatments. This approval affects doctors, patients, and drug makers by bringing this important drug back to the market. Expect Wellcovorin to be available soon, helping folks without extra cost surprises.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Wellcovorin NDA Approval Restored
The FDA approved the previously withdrawn new drug application (NDA) for Wellcovorin (leucovorin calcium) tablets in strengths equivalent to 5 mg base and 25 mg base. The Agency says it initiated this action on the basis of new data and published this notice; the approval returns the drug to the market and affects doctors, patients, and drug makers.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in